Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Heliyon|November 11, 2024
Changes in exposure to environmental contaminants in the aftermath of Hurricane Maria among pregnant women in northern Puerto RicoDeborah J Watkins, Héctor R Torres Zayas, Michael Welton, et al.
Journal of Community Genetics|August 11, 2021
Participation in genetic research among Latinx populations by Latin America birth-residency concordance: a global studyTimothy De Ver Dye, Zahira Quiñones Tavarez, José G Pérez Ramos, et al.
Journal of Clinical Psychology in Medical Settings|January 19, 2026
Targeting Chronic Pain in Primary Care Settings Using Behavioral Health Consultants: A Pilot Study Implementing Brief Cognitive Behavioral Therapy for Chronic PainJeffrey L Goodie, Kathryn E Kanzler, Cindy A McGeary, et al.
The World Allergy Organization Journal|April 3, 2019
Learnings from real-life experience of using omalizumab for chronic urticaria in Latin AmericaIvan Cherrez-Ojeda, Marcus Maurer, Jonathan A Bernstein, et al.
Journal of Investigational Allergology & Clinical Immunology|February 27, 2020
Severe Cutaneous Adverse Reactions to Drugs in Latin America: The RACGRAD StudyD V Rojas Mejía, R D Zwiener, R Cardona Villa, et al.
Journal of Medicinal Chemistry|March 15, 2021
Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 ReceptorFrancis S Willard, David B Wainscott, Aaron D Showalter, et al.
JCI Insight|July 31, 2020
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistFrancis S Willard, Jonathan D Douros, Maria Bn Gabe, et al.
Microbiology Resource Announcements|September 19, 2022
Complete Genome Sequence of Microbacterium foliorum Bacteriophage LibrieSergei A Markov, Nygil L Arms, Kayla J Boyce, et al.
Journal of Medicinal Chemistry|December 14, 2017
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes MellitusChafiq Hamdouchi, Pranab Maiti, Alan M Warshawsky, et al.
Journal of Medicinal Chemistry|October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Pageof 5